President Donald Trump’s plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he’s even signed the executive order set for Monday that, if implemented, could lower the cost of some drugs. Trump has promised that his plan — which is likely to tie the price of medications covered by Medicare and administered in a doctor’s office to the lowest price paid by other countries — will significantly lower drug costs. “I will be instituting a MOST FAVORED NATION’S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World,” the Republican president posted on social media on Sunday, pledging to sign the order on Monday morning at the White House.

Elon Musk, who chairs the Department of Government Efficiency Commission, acknowledged in a brief social media post that a preliminary version of President Donald Trump’s gold visa card program is currently underway. The visa, priced at $5 million, is being tested before a wider release.
“We’re doing a quiet trial to make sure the system works properly. Once it is fully tested, it will be rolled out to the public with an announcement by the President,” Musk wrote Sunday on X in response to a Wired report.
President Trump originally introduced the concept in February, promoting it as a strategy to bring affluent international investors into the U.S.

Ceasefire negotiations aimed at ending the war in Gaza will take place immediately after the release of US-Israeli hostage Eden Alexander, CNN reported on Monday. “We’re going to go into immediate peace deal negotiations,” a source knowledgeable about the talks between the US and Hamas said. The Wall Street Journal reported on Monday, citing Arab sources, that indirect talks between Hamas and Israel are being held regarding the release of additional hostages, a ceasefire, and the resumption of humanitarian aid into the Gaza Strip. According to these sources, Israel will send a delegation to Cairo later on Monday to participate in the negotiations.

WATCH:

Yael and Adi Alexander, residents of New Jersey, have been fighting for the release of their son, Eden, since he was abducted from his army base during the October 7 assault. The news that their son was to be immediately released caught his parents by complete surprise on Sunday. They were aware that the Trump administration was holding talks with Hamas about their son’s release but the breakthrough took them by surprise. “The entire family is now together on the way to Israel,” said Eden’s father, Adi Alexander. ” We were completely surprised to receive the call from Witkoff. We knew about the talks, but not about such a dramatic development.

The Hamas terror organization on Monday morning announced that US-Israeli hostage Edan Alexander will be released on Monday, but did not disclose the time and location. The Trump administration is exploring the possibility that, following Alexander’s release, US special envoy Steve Witkoff will fly him and his parents to Qatar to meet President Trump, Ynet reported. However, such a scenario is dependent on Alexander’s condition upon his release. A hostage release ceremony will not be held before Alexander is handed over to the Red Cross, a Hamas official told AFP. IDF forces are preparing to secure a safe passage in Gaza for Alexander’s release. A senior Israeli source said: “We’re preparing to receive Edan Alexander sometime today.

The family of Rabbi Sholom Ber Lipskar zt”l, rov in Bal Harbour, Florida, concluded the shivah mourning period this week.
In the days following his petirah, expressions of grief and support poured in from across Florida and around the globe, as people remembered Rabbi Lipskar’s immense contributions and enduring legacy.
Among the many who came to offer condolences was U.S. Senator Rick Scott, who traveled to Florida immediately after casting a vote in Washington, D.C. He went straight to the shivah house, where he spent time with Rabbi Lipskar’s widow, Rebbetzin Chani Lipskar, and their family.

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 pounds (15 kilograms). That’s according to the study funded by Lilly, which was published Sunday in the New England Journal of Medicine. Both drugs are part of a new class of medications that work by mimicking hormones in the gut and brain that regulate appetite and feelings of fullness. But tirzepatide targets two such hormones, known as GLP-1 and GIP, while semaglutide targets GLP-1 alone, said Dr.

Holocaust survivor Magda Baratz a”h, was niftar at age 96 just days after learning of the petirah of her beloved great-grandson, Master Sergeant Asaf Cafri Hy”d, who fell in battle while defending Israel in Gaza. Baratz, a survivor of both Auschwitz and Bergen-Belsen, was in Germany as the guest of honor at a Holocaust Remembrance Day ceremony marking 80 years since the liberation of the infamous Bergen-Belsen concentration camp, when the tragic news was delivered. Her grandson Hagai, the father of Asaf, had accompanied her on the trip. He received word of his son’s death shortly after their arrival. Asaf, 26, a resident of Beit Hashmonai and a reserve soldier in the IDF’s Armored Corps, was killed by sniper fire from a Hamas terror cell in Beit Hanoun.